Horizon Therapeutics (Amgen)

Horizon Therapeutics (Amgen) is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Horizon Therapeutics (Amgen) products.

Drugs from Horizon Therapeutics (Amgen) supported via NPP

BrandGenericCategoryIndication
Ravictiglycerol phenylbutyrateMetabolic (UCD)Urea cycle disorders
KrystexxapegloticaseRheumatology (Gout)Chronic refractory gout

How NPP access to Horizon Therapeutics (Amgen) products works

Reserve Meds sources Horizon Therapeutics (Amgen) products from DSCSA-compliant US specialty wholesalers, not from parallel-import channels. All supply is US-FDA-provenance.

Not affiliated with Horizon Therapeutics (Amgen)

Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Horizon Therapeutics (Amgen).

Start a request

Start a request for a Horizon Therapeutics (Amgen) product

AI disclosure & medical review. Content on this page is reviewed by Reserve Meds's AI clinical and regulatory review agents. A US-licensed human pharmacist (sourced through Altima Care, a US-licensed specialty wholesaler) reviews every prescription before dispensing. Regulatory posture is AI-summarized and not legal advice; case-specific questions route to retained outside counsel. Last medically reviewed: .
WhatsApp